Susana Almeida was nominated to her current position as Secretary General of the International Generic and Biosimilar medicines Association (IGBA) in January 2024.
She has spent over 20 years of contributing to the European and international generic and biosimilar medicines industries, frequently interacting with trade bodies and companies.
Susana brings significant experience in the process of international harmonisation of standards through the International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), a non-profit organisation that convenes regulatory authorities and pharmaceutical industry members to discuss scientific and technical aspects of drug registration.
Before joining IGBA, Susana was Clinical Development and Safety Director at Medicines for Europe. She has also overseen clinical trials in Europe and in North America, with her experience spanning positions at pharmaceutical companies and clinical research organisations. She earned her doctorate degree in Clinical Pharmacology from the Faculty of Medicine, Universidad Autònoma de Barcelona and has authored several scientific papers and patents.
Susana believes that generic and biosimilar medicines industries play a vital role in fostering worldwide patient access to quality-assured medicines and that a strong off-patent sector is essential to a healthy medicines ecosystem.